PORKEROpen the app

House bill · 119th Congress · Latest step: Introduced

Prescription Drug Price Relief Act of 2025

H.R. 3546Introduced May 21, 2025Policy area: Health

Official title: To significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries.

Sponsor: Rep. Ro Khanna D-CA
Open in Bill Explorer →

Where it went

Latest action: May 21, 2025 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Cost and committee reports

Official records Congress.gov attaches to H.R. 3546.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of July 17, 2026). Not every bill gets one.

From the Congress.gov bill record for H.R. 3546, last updated July 17, 2026. PORKER’s copy was retrieved September 13, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.

Vote results

No recorded roll-call votes on this bill in PORKER’s records (voice votes and unanimous consent are not roll calls; roll-call records start in 2011).

Cosponsors

4 cosponsors — 4 Democrats

0 of 4 cosponsors (0%) are from the other party.

Yassamin Ansari (D-AZ), Pramila Jayapal (D-WA), Ilhan Omar (D-MN), Janice Schakowsky (D-IL).

More from the sponsor

Other 119th Congress bills sponsored by Rep. Ro Khanna.

Related bills

Relationships as recorded by Congress.gov.

Sponsor’s state and district

California in Congress · CA-17 district

Open in Bill Explorer →

Data as of Sep 25, 2026 · bill record checked by PORKER from Congress.gov · votes from Senate.gov and the House Clerk. PORKER is non-partisan.